Institution
First Hospital of Shanxi Medical University
- 66running trials
- 23closed trials
- 7,973publications (OpenAlex)
Running trials
Not yet recruiting
A Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NEC
Not yet recruiting
A Phase 3 Study of Povorcitinib Phosphate in Chinese Adults With Nonsegmental Vitiligo
Recruiting
A Study of ATG-201 in Adult Participants With Autoimmune Diseases
Recruiting
Recruiting
Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis
Recruiting
Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
Recruiting
Not yet recruiting
Recruiting
Recruiting
Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With Hypertension
Not yet recruiting
Ongericimab Injection Reducing Recurrence of Ischemic Stroke
Recruiting
Recruiting
A Study of E6742 in Participants With Systemic Lupus Erythematosus
Recruiting
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Not yet recruiting
Recruiting
Recruiting
Study of the Efficacy and Safety of ICP-332 in Participants With Chronic Spontaneous Urticaria
Not yet recruiting
Recruiting
Active, not recruiting
Efficacy and Safety of ZT006 in Overweight and Obese Participants
Recruiting
Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA)
Recruiting
Near-infrared Light Therapy Device for Mild-Moderate Alzheimer's Disease (NirsCure-03A)
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps
Recruiting
Recruiting
Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)
Recruiting
Recruiting
Not yet recruiting
Recruiting
Study of XNW28012 in Subjects With Metastatic Pancreatic Cancer Who Received Prior Systemic Therapy
Recruiting
Recruiting
ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 Overexpression
Not yet recruiting
Active, not recruiting
Active, not recruiting
A Phase 1b Study of GKL-006 Injection in Patients With Unresectable Hepatocellular Carcinoma
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
Recruiting
Phase I Trial of Subcutaneous VDJ010 In Healthy Subjects and Patients With Ulcerative Colitis
Active, not recruiting
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders
Showing 50 of 66.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Hepatitis B4 recruiting
- Lung cancer4 recruiting
- Colorectal cancer3 recruiting
- Gastric and oesophageal cancer3 recruiting
- Heart failure3 recruiting
- Liver and biliary tract cancer3 recruiting
- Obesity3 recruiting
- Psoriasis3 recruiting
- High blood pressure2 recruiting
- Liver cirrhosis2 recruiting
- Lupus (SLE)2 recruiting
- Neuromyelitis optica (NMOSD)2 recruiting
- Pancreatic cancer2 recruiting
- Ulcerative colitis2 recruiting
- Alzheimer disease1 recruiting
- Amyloidosis1 recruiting
- Bladder cancer1 recruiting
- Childhood cancers1 recruiting
- Chronic rhinosinusitis with nasal polyps1 recruiting
- Chronic spontaneous urticaria1 recruiting
- Coronary artery disease1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Kidney cancer1 recruiting
- Myasthenia gravis1 recruiting
- Myotonic dystrophy1 recruiting
- Neuroendocrine tumours1 recruiting
- Osteoporosis1 recruiting
- Prostate cancer1 recruiting
- Psoriatic arthritis1 recruiting
- Rheumatoid arthritis1 recruiting
- Sjögren's disease1 recruiting
- Stroke1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
- Type 2 diabetes1 recruiting
- Vitiligo1 recruiting
Closed trials
Completed
Completed
Completed
Efficacy of MI078 Capsules in Treating Postpartum Depression
Completed
To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus
Completed
Completed
Completed
Terminated
A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid Arthritis
Completed
A Study of Daridorexant in Chinese Patients With Insomnia Disorder
Completed
Efficacy and Safety of Minocycline in Patients With Moderate to Severe Acute Ischemic Stroke
Completed
A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects.
Completed
Completed
Completed
Completed
Completed
Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen Ovale
Completed
Completed
Completed
GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer
Completed
Clinical Study of HMPL-689 for Relapsed/Refractory Marginal Zone Lymphoma and Follicular Lymphoma
Completed
Completed
Efficacy and Safety of Flos Gossypii Flavonoids Tablet in the Treatment of Alzheimer's Disease
Completed
A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B
Registry name variants (5)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
First Hospital of Shanxi Medical University
Taiyuan, Shanxi 030001
53 trials
The First Hospital of Shanxi Medical University
Taiyuan, Shanxi 030001
32 trials
Shanxi Medical University First Hospital
Taiyuan, Shanxi 30001
2 trials
Contact: Novo Nordisk
Department of Psychiatry, First Hospital of Shanxi Medical University
Taiyuan, Shanxi 030001
1 trial
First Hospital of Shanxi Medical University
Xi'an
1 trial
NCT06632262A Phase 2 Clinical Study of ABSK061 and ABSK043
Contact: Yilai Song
Conditions
Diseases this institution publishes on or runs trials for.
- Depression34 works · 1 trial
- Kidney cancer21 works · 1 trial
- Migraine15 works · 2 trials
- Thyroid cancer14 works · 0 trials
- Neuromyelitis optica (NMOSD)10 works · 3 trials
Institution data: ROR 02vzqaq35 (CC0-1.0)Updated 15 Nov 2026